Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients-Reference-Cited by-同舟云学术

Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients

Published:2022-12-07 Issue:1 Volume:37 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clinical Transplantation

Author:

Khairallah Pascale¹^ORCID,Robbins‐Juarez Shelief²,Patel Shefali³,Shah Vaqar⁴,Toma Katherine⁵,Fernandez Hilda³^ORCID,Dube Geoffrey K.³,King Kristen³,Mohan Sumit³^ORCID,Husain Syed Ali³^ORCID,Morris Heather³,Crew Russell John³

Affiliation:

1. Section of Nephrology Baylor College of Medicine Houston Texas USA

2. Department of Internal Medicine Duke University Medical Center Durham North Carolina USA

3. Division of Nephrology Columbia University Irving Medical Center New York New York USA

4. Department of Medicine SUNY University at Buffalo Buffalo New York USA

5. Jersey Coast Nephrology and Hypertension Associates Brick New Jersey USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14853

Reference32 articles.

1. OPTN / SRTR 2018 Annual Data Report: Kidney

2. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

3. Kidney transplant graft outcomes in 379 257 recipients on 3 continents

4. Identifying Specific Causes of Kidney Allograft Loss

5. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing immunosuppression in liver transplantation: A narrative review;Hepatobiliary & Pancreatic Diseases International;2024-10

2. A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes;BioDrugs;2024-08-15

3. Granulomatous Tubulointerstitial Nephritis in a Kidney Allograft: Treatment with Interleukin-6 Receptor Antagonist Stabilises Kidney Function;Journal of Clinical Medicine;2024-06-11

4. Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study;Journal of Clinical Medicine;2023-11-17